Smad4 Haploinsufficiency and Its Role in Tumor Formation
Author Information
Author(s): Alberici Paola, Gaspar Claudia, Franken Patrick, Gorski Marcin M, de Vries Ingrid, Scott Rodney J, Ristimäki Ari, Aaltonen Lauri A, Fodde Riccardo
Primary Institution: Erasmus MC, Rotterdam, The Netherlands
Hypothesis
Does Smad4 haploinsufficiency contribute to tumorigenesis in juvenile polyposis syndrome?
Conclusion
Smad4 haploinsufficiency significantly inhibits TGF-β and BMP signaling, leading to differential gene expression that likely contributes to tumor formation.
Supporting Evidence
- Haploinsufficiency at the SMAD4 locus is sufficient to initiate tumorigenesis in juvenile polyposis syndrome.
- Intermediate inhibitory effects on TGF-β and BMP signaling were observed in Smad4+/- cells.
- Genome-wide expression profiling identified 79 differentially expressed genes linked to Smad4 dosage.
Takeaway
If you have one working copy of a gene called Smad4, it can still cause problems and lead to tumors, even if the other copy is fine.
Methodology
The study involved immunohistochemistry analysis of juvenile polyps, TGF-β and BMP signaling assays, and genome-wide expression profiling.
Potential Biases
Potential bias in interpreting immunohistochemical results due to subjective assessment of staining patterns.
Limitations
The total number of tumors analyzed is small, and the study may not account for all genetic variations affecting tumorigenesis.
Participant Demographics
Juvenile polyps from six unrelated patients with known SMAD4 germline mutations.
Statistical Information
P-Value
p<0.001
Statistical Significance
p<0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website